Clinical Trial Update: Levetiracetam in Post-Traumatic Stress Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials of levetiracetam for post-traumatic stress disorder conducted at Duke University have completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Duke University | Conditions: Post-Traumatic Stress Disorder | Phase 2, Phase 3 | Status: COMPLETED